R2101246 |
BSJ-03-123 |
BSJ-03-123 is a Selective Cdk6 degrader. BSJ-03-123 exploits protein-interface d
|
R2101247 |
VH032-C10-NH2 dihydrochloride |
(S,R,S)-AHPC-C10-NH2 dihydrochloride (VH032-C10-NH2 dihydrochloride) is a synthe
|
R2101248 |
VH032-C4-NH2 |
(S,R,S)-AHPC-C4-NH2 is a synthesized E3 ligase ligand-linker conjugate that inco
|
R2101249 |
AT1 |
BRD4 degrader AT1 is a highly selective Brd4 degrader based on PROTAC technology
|
R2101250 |
dBET57 |
dBET57 is heterobifunctional degrader of BRD4 based on the PROTAC technology, ex
|
R2101251 |
(S)-AZD6738 |
(S)-Ceralasertib is a potent and selective inhibitor of sulfoximine morpholinopy
|
R2101252 |
MS4078 |
MS4078 is an anaplastic lymphoma kinase (ALK) PROTAC. It has a Kd of 19 nM for b
|
R2101253 |
(S)-JQ-35 |
(S)-JQ-35 (TEN-010) is an inhibitor of the Bromodomain and Extra-Terminal (BET)
|
R2101254 |
A1874 |
A1874 is a nutlin-based and BRD4-degrading PROTAC which induces BRD4 degradation
|
R2101255 |
TL13-112 |
TL13-112 is a selective degrader of ALK-PROTAC and inhibits ALK activity (IC50:
|
R2101256 |
CCT367766 |
CCT367766 is the PROTAC-based pirin targeting protein degradation probe, deplete
|
R2101258 |
MS1943 |
MS1943 is a orally bioavailable EZH2 selective degrader(IC50 of 120 nM).
|
R2101259 |
SGK3 degrader-1 |
PROTAC SGK3 degrader-1 (SGK3-PROTAC1) is a PROTAC conjugate of the 308-R SGK inh
|
R2101260 |
VH032-C4-NH2 dihydrochloride |
(S,R,S)-AHPC-C4-NH2 dihydrochloride is a synthesized E3 ligase ligand-linker con
|
R2101261 |
XZ739 |
XZ739 is a CRBN-based PROTAC Bcl-XL decompressant, which acts on Molt-4 cells. A
|
R2101262 |
INNO206 |
|
R2101263 |
TL12-186 |
TL12-186 is a CRBN-dependent multi-kinase PROTAC decompressor.Including CDK, BTK
|
R2101265 |
TL13-12 |
TL13-12 is a selective degrader of ALK-PROTAC and inhibits ALK activity (IC50: 0
|
R2101266 |
VH032-C5-COOH |
(S,R,S)-AHPC-C5-COOH (VH032-C5-COOH) is a synthesized E3 ligase ligand-linker co
|
R2101267 |
TD-165 |
TD-165 is a PROTAC-based cereblon (CRBN) degrader. TD-165 comprises a cereblon (
|
R2101268 |
BAY-1797 |
BAY-1797 is an orally active and selective P2X4 antagonist (IC50: 211 nM against
|
R2101269 |
Sparsentan |
Sparsentan is a first-in-class orally active and highly potent dual endothelin A
|
R2101270 |
Ripretinib |
Ripretinib is an orally bioavailable inhibitor of KIT and PDGFRA.
|
R2101271 |
Larotrectinib sulfate(LOXO101) |
LOXO-101 is an oral active and specific ATP-competitive inhibitor of tropomyosin
|
R2101257 |
UNC6852 |
UNC6852 is a selective degrader that targets polycomb repressive complex 2 (PRC2
|